Author:
Gu Xuefeng,Fu Maoying,Ge Zhijun,Zhan Feng,Ding Yuqin,Ni Huihui,Zhang Wei,Zhu Yanfang,Tang Xiaojun,Xiong Lin,Li Jiang,Qiu Liang,Mao Yuan,Zhu Jin
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Fu, M. et al. High expression of inositol polyphosphate phosphatase-like 1 associates with unfavorable survival in hepatocellular carcinoma. Int. J. Clin. Exp. Pathol. 6, 2515–2522 (2013).
2. Xie, C. et al. Interferon-beta gene-modified human bone marrow mesenchymal stem cells attenuate hepatocellular carcinoma through inhibiting AKT/FOXO3a pathway. Br. J. Cancer 109, 1198–1205 (2013).
3. Guo, X., Jin, Y., Qian, G. & Tu, H. Sequential accumulation of the mutations in core promoter of hepatitis B virus is associated with the development of hepatocellular carcinoma in Qidong, China. J. Hepatol. 49, 718–725 (2008).
4. Poon, D. et al. Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol. 10, 1111–1118 (2009).
5. Siegel, R., Naishadham, D. & Jemal, A. Cancer statistics, 2013. CA Cancer J. Clin. 63, 11–30 (2013).
Cited by
44 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献